The Latest Cardiac and Vascular News
– As the world’s first ring-type medical device to monitor heart signals, CART-I continually measures atrial fibrillation 24/7 – In-house developed AI technology is used to provide significant medical data to patients and medical professionals, leading to an increased atrial fibrillation diagnosis rate – Discount promotion is planned in Britain […]
– Etripamil significantly decreased heart rate during SVT episodes and independent of conversion to SR – – HR changes occurred within 5 minutes and were sustained for 60 minutes – – Data presented at AHA Scientific Sessions 2021 – MONTREAL and CHARLOTTE, N.C., Nov. 15, 2021 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical […]
– Abbott included on DJSI for 17 consecutive years for strong environmental, social and governance (ESG) performance – Top score in the Health Care Equipment & Supplies sector reflects Abbott’s 2030 Sustainability Plan focus on innovating for greater access to life-changing technologies and breaking down barriers to health equity ABBOTT […]
The implant took place at the University Medical Centre Utrecht, The Netherlands November 15, 2021 01:00 AM Eastern Standard Time PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic […]
Analysis from GALACTIC-HF Shows Treatment with Omecamtiv Mecarbil Associated with Significant Reduction in the Risk of Stroke Data on Analog to CK-3828136 Adds Preclinical Support for Cardiac Troponin Activation as Novel Mechanism to Increase Cardiac Function without Impacting Cardiac Efficiency SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — […]
Post hoc analysis of pooled clinical data from the SOLOIST and SCORED trials supporting benefit of sotagliflozin presented at the virtual American Heart Association Scientific Sessions 2021, including: Sotaglifozin significantly reduced total cardiovascular deaths, hospitalizations for heart failure, and urgent visits for heart failure across the full range of kidney […]
WALTHAM, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced our financial results for the quarter ended September 30, 2021, and recent events. “We continue to make […]
WARREN, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the third quarter ended September 30, 2021. “We remain focused on […]
ST. LOUIS, Nov. 15, 2021 (GLOBE NEWSWIRE) — Stereotaxis (NYSE:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces today that BJC HealthCare has become the first health care system in the midwest to offer the Genesis RMN system, advancing electrophysiology patient care and expanding access to […]
The reported prevalence of HCM ranges from 1 in 200* to 1 in 500† people in the general population, however it is estimated that many patients remain undiagnosed, underscoring need for increased awareness and education Jared Butler, professional basketball player living with HCM, to partner on education campaign and share his […]
